Journal
BIOCONJUGATE CHEMISTRY
Volume 24, Issue 4, Pages 578-585Publisher
AMER CHEMICAL SOC
DOI: 10.1021/bc300515t
Keywords
-
Categories
Funding
- MICINN [BIO2008-0447-C03-02, CSD2006-0007]
- MINECO [SAF2011-24899, AGL2010-22200-C02-02]
- European Union (EPIZONE Network of Excellence) [FOOD CT-2006-016236]
- Generalitat de Catalunya [SGR2009-00492]
Ask authors/readers for more resources
Multimeric presentation, a well-proven way of enhancing peptide immunogenicity, has found substantial application in synthetic vaccine design. We have reported that a combination of four copies of a B-cell epitope with one of a T-cell epitope in a single branched construct results in a peptide vaccine conferring total protection against foot-and-mouth disease virus in swine, a natural host (Cubillos et al. (2008) J. Virol. 82, 7223-7230). More recently, a downsized version of this prototype with only two copies of the B epitope has proven as effective as the tetravalent one in mice. Here we evaluate three approaches to bivalent platforms of this latter type, involving different chemistries for the conjugation of two B epitope peptides to a branching T epitope. Comparison of classical thioether, reverse thioether (Monso et al. (2012) Org. Biomol. Chem. 10, 3116-3121) and thiol-ene conjugation chemistries in terms of synthetic efficiency clearly singles out the latter, maleimide-based strategy as most advantageous. We also examine how minor structural differences among the conjugates-including the N- or C-terminal attachment of the B epitope to the branching T epitope bear on the immunogenicity of these vaccine candidates, with the maleimide-based conjugate again emerging as the most successful.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available